Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Method for the location of primary wear scars from retrieved metal on metal hip replacements

  • Garima Govind1Email author,
  • Johann Henckel1,
  • Harry Hothi1,
  • Shiraz Sabah1,
  • John Skinner1 and
  • Alister Hart1
BMC Musculoskeletal Disorders201516:173

https://doi.org/10.1186/s12891-015-0622-2

Received: 16 October 2014

Accepted: 3 July 2015

Published: 30 July 2015

Abstract

Background

Retrieved metal-on-metal acetabular cups are valuable resources in investigating the wear behaviour of failed hip implants, but adequate methods to do so are lacking. To further contribute to addressing this issue, we developed a method to detect the in vivo location of the primary wear scar of an explanted cup.

Methods

We proposed a new method in which thirteen patients with failed metal hip resurfacings were recruited, and their acetabular components retrieved. A 3D wear map was generated and the precise location of the primary wear scar in each cup was identified using a coordinate measuring machine. This wear scar location was noted in relation to the features on the acetabular cup. Having identified the location of the wear scar, this 3D positional map was co-registered to the implant on the patient’s pelvic 3D CT scan.

Results

Using our proposed technique, we were able to demonstrate that the in vivo position of the primary wear scar in explanted metal acetabular cups can be variable.

Conclusions

This method has utilised existing techniques to better understand the three-dimensional properties of wear behaviour, and may be a method which can be used in further studies to investigate variables that affect the position of the primary wear scar.

Keywords

Joint mechanics Hip arthroplasty Wear scar Acetabular cup

Background

Metal-on-metal (MoM) hip implants proved to be popular, but had a high failure rate, and lead to a dangerous level of metal ions into the blood stream [14]. With patient factors a very important consideration, the pattern of failure due to biomechanical implications as a result of the patient’s anatomy must be examined [5, 6]. Pin pointing the in vivo location of the primary wear scar (WS1) may allow us to correlate a number of factors to help ascertain the tribology behind qualitative patterns of wear.

Limited work has been previously done to identify the location of the WS1 in explanted acetabular components of a MoM hip replacement with its in vivo location. Published work exploring the significance of wear scar location has so far been limited to an in vitro study [7]. In this study, Angadji et al. used schematic drawings to map two-dimensional acetabular wear scar locations. However as this study was done using a hip joint simulator, there was no method that described the process of co registering the WS1 with its in vivo location.

This limited previous work highlights the methodology is missing in this discipline, and our study aimed to address this gap in both technique and knowledge of in vivo wear scar location. Ours was a study aimed to develop a novel technique which allowed the mapping of a primary wear scar with its 3D pre-explantation in vivo location.

Methods

As the purpose of this paper was to devise a novel technique that could use explanted acetabular cups to map the WS1 with its pre-explanation in vivo location, the method consisted of two main stages: retrieval analysis and 3D CT co-registration.

Patients

CT scans for thirteen patients (Table 1) who had undergone a revision of their hip resurfacing that had subsequently failed was gathered. The two inclusion criteria were that the acetabular component needed to be available for physical analysis and that pre-revision CT scans of the patients were required. The mean age of the patients at the time of failure was 51.8 years and the mean period of between implant insertion and failure was 47.5 months. Twelve patients had been fitted with a Birmingham Hip Replacement (BHR) system. One patient had a Cormet system. Four patients had an implant on their left hip. The remaining nine patients had an implant on their right hip. One patient had a bilateral BHR but only the right hip was used for the purposes of this study. The internal diameter ranged from 42-54mm (Table 1). Informed written consent for this study was obtained from all patients.
Table 1

A summary of the patient demographics and implant details used in this study

Patient

Implant type

Femoral head radius (mm)

Acetabular cup radius (mm)

Age at insertion (years)

Time implanted (months)

1

BHR

50

56

45

23

2

BHR

46

54

50

25

3

BHR

50

56

68

60

4

BHR

46

52

54

75

5

BHR

42

50

57

56

6

BHR

42

48

59

31

7

BHR

42

48

46

63

8

BHR

50

56

56

84

9

BHR

42

50

55

44

10

BHR

42

50

38

33

11

BHR

54

60

63

63

12

BHR

54

60

47

23

13

Cormet

52

58

36

37

Retrieval analysis

To determine the location of the wear scar, each of the bearing surfaces of the cup were measured using a Zeiss Prismo (Carl Zeiss Ltd, Rugby, UK) coordinate measuring machine (CMM). Previously published protocols [8] were used to take up to 300 000 unique data points on the surface by translating a 2mm ruby stylus along 400 polar scan lines. An iterative least square fitting method was used to analyse the raw data, allowing a 3D wear map of the cup under study to be generated (Fig. 1). An unworn cup should have had a uniform depth throughout the cup, and any areas of increased depth reflected locations of wear patches. The WS1 could be visualised according to their location according to concentric zone (Fig. 2). The location of WS1 was also noted in terms of degrees clockwise from the acetabular features (Fig. 3) which were used as markers for rotational identification.
Fig. 1

An example of a CMM and a wear map. a An acetabular cup placed in a coordinate measuring machine, with its corresponding 3D wear map in the inset (b) a close up of the 3D wear map, showing the wear scar location

Fig. 2

Distribution of primary wear scars. The schematic distribution of the 13 wear scars superimposed on a picture of a metal acetabular cup and arranged according to whether they are found in the outer (blue), middle (orange) or inner (green) zones

Fig. 3

Acetabular features. An image of a metal acetabular cup, clearly showing the acetabular features which are circled in red

3D CT and co-registration

A low dose 3DCT protocol was followed [9], generating an image of the pelvis. The in vivo location of WS1 could be co-registered on this image as the location of the WS1 was known in relation to the acetabular cup rim and also in relation to the acetabular features. First, the acetabular features were located on the 3D CT image. Next, the angle in degrees between these fins and the WS1 was measured using the appropriate measuring tools. Finally, the vertical distance of the WS1 from the acetabular cup rim was measured. This gave us the epicentre of the WS1 and hence, the location of the WS1 of an explanted acetabular cup could be co-registered with its in vivo location (Fig. 4).
Fig. 4

3D CT methodology. An example of the co-registration process within the software used, showing the in vivo position of the implant within the pelvis

Acetabular fins are intended add to the component’s stability [10], but in this case they could be used as a reference point in this co-registration process. Due to the spherical nature of the acetabular cup, without these acetabular fins the orientation of the explanted cup in vivo would not have been possible.

Ethical approval

Ethical approval for this project was granted for this project in 2009 by the Integrated Research Application System Research Ethics Committee (number 07/QQ0401/25).

Results

Using the method which was discussed the WS1 was identified for all 13 components. The out-of-roundness machine was able to take circular measurements at 0.1° intervals around the acetabular cup rim and also in 0.5mm increments down from the acetabular cup rim. The location of the acetabular features was also noted successfully in all cases, allowing the co-registration of the in vivo location of the WS1 to be visualised. A diagram was then produced showing a 3D representation the location of each of the thirteen WS1 on a single acetabular cup. This allowed us to appreciate the range of their locations, with reference to the anterior pelvic plane, according to quadrants (Fig. 5).
Fig 5

Location of primary wear scars. An image of a metal cup on which each of the 13 wear scars is superimposed, according to which quadrant the wear scar was positioned

Discussion

The distribution of the location of the in vivo WS1 can be reported as follows: six were in the upper outer quadrant; three were in the lower outer quadrant; one was in the upper inner quadrant; and three were in the lower inner quadrant. These results clearly show that the location of the in vivo WS1 can be very variable, which does not fit with the current theory of edge loading [6, 7]. Further work can be done to correlate a range of factors with the location of WS1, and as such, the method devised here may be of huge importance. We did not encounter any components where this technique could not be used.

This is a novel method because it allows us to use an explanted component and work retrospectively to co-register the WS1 from this explanted component with what would have been its in vivo location. Mapping of wear scars of large numbers of failed components, and hence the application of our technique, may help us better investigate the qualitative three-dimensional properties of wear behaviour and correlate the location of wear with a number of variables. Knowledge of in vivo wear scar location may be key to assessing the importance of patient factors on wear properties and failure patterns.

The clinical value of the information obtained from this method will be of interest to surgeons who can suggest a more accurate patient-based prediction of implant longevity pre-revision surgery. Furthermore, it will be of use in the context of explaining wear behaviour of hip implants because the effect and importance of many variables are currently unknown. This is because of the limited investigations gathered out with respect to the qualitative properties of hip wear, such as primary wear scar location.

The mean period of implant failure is just under four years for our patient sample. This short length of time between implantation and failure may be explained by a selection bias, as we did not include patients whose implants had not failed, even though the implant may have had a substantial wear scar. Hence, an interesting aspect that has been unexplored in this study is whether there is a correlation between the period of implant insertion and the magnitude of the wear scar, This was one limitation of the study and in future, a method may be devised that allows us to visualise the in vivo primary wear scar pre-failure.

Conclusions

We have developed a method which can be used as part of future mechanical and tribological studies looking into the failure of MoM hip implants. Future studies should investigate variables that affect position of the WS1, and our technique may be integral to these studies. Examples of variables could include component position, pelvic tilt, gender and joint reaction force. In doing so, we may be able to better understand the implant, surgical and patient factors that lead to implant failure and use this knowledge to predict the suitability of patients to certain joint replacement procedures and its prognosis.

Abbreviations

MoM: 

Metal-on-metal

WS1

Primary wear scar

BHR: 

Birmingham Hip Replacement

CMM: 

Coordinate measuring machine

Declarations

Acknowledgements

We are grateful to Gwynneth Lloyd for assistance with database access for our study.

Authors’ Affiliations

(1)
University College London, Institute of Orthopaedics and Musculoskeletal Science, Royal National Orthopaedic Hospital

References

  1. Pivec R, Johnson A, Mears C, Mont A. Hip Arthroplasty. Lancet. 2012;380:1768.View ArticlePubMedGoogle Scholar
  2. Heneghan C, Langton D, Thompson M. Ongoing problems with metal-on-metal hip implants. BMJ. 2012;344, e1349.View ArticlePubMedGoogle Scholar
  3. De Haan R, Pattyn C, Gill HS, Murray DW, Campbell PA, De Smet K. Correlation between inclination of the acetabular component and metal ion levels in metal-on-metal hip resurfacing replacement. J Bone Joint Surg (Br). 2008;90:1291–7.View ArticleGoogle Scholar
  4. Smith A, Dieppe P, Howard P, Blom A. Failure rates of metal-on-metal hip resurfacings: analysis of data from the National Joint Registry for England and Wales. Lancet. 2012;380:1759–66.View ArticlePubMedGoogle Scholar
  5. Matthies A, Henckel A, Cro S, Suarez A, Noble PC, Skinner J, et al. Predicting wear and blood metal ion levels in metal-on-metal hip resurfacing. J Orthop Res. 2014;32:167–74.View ArticlePubMedGoogle Scholar
  6. Mellon SJ, Grammatopolous G, Andersen MS, Pegg EC, Pandit HG, Murray DW, et al. Individual motion patterns during gait and sit-to-stand contribute to edge loading risk in metal-on-mtal hip resurfacing. Proc I Mech Eng H. 2013;227:799–810.View ArticleGoogle Scholar
  7. Angadji A, Royale M, Collins S, Shelton J. Influence of cup orientation on the wear performance of metal-on-metal hip replacements. Proc I Mech Eng H. 2009;224:449–57.View ArticleGoogle Scholar
  8. Bills PJ, Rascan R, Underwood RJ, Cann P, Skinner J, Hart AJ, et al. Volumetric wear assessment of retrieved metal-on-metal hip prostheses and the impact of measurement uncertainty. Wear. 2012;274:212–9.View ArticleGoogle Scholar
  9. Henckel J, Richards R, Lozhkin K, Harris S, Rodriguez y Baena FM, Barrett AR, et al. Very low dose computed tomography for planning and outcome measurement in knee replacement. J Bone J Surg Br. 2006;88:1513–8.View ArticleGoogle Scholar
  10. Baleani M, Fognani R, Toni A. Initial stability of a cementless acetabular cup design: experimental investigation on the effect of adding fins to the rim of the cup. Artif Organs. 2001;25:664–9.View ArticlePubMedGoogle Scholar

Copyright

© Govind et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement